Vietnam's homegrown Nanocovax COVID-19 vaccine candidate to be assessed by Indian institute
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nanocovax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam.
Hanoi (VNA) - The Translational Health Science & Technology Institute (THSTI) of India will evaluate immunogenicity of the Made-in-Vietnam Nanocovax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam.
A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23.
Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nanocovax to the THSTI for assessment.
Vietnamese Ambassador to India Pham Sanh Chau affirmed that the collaboration with the THSTI holds significant meaning for Nanogen in the research and development of the vaccine candidate.
The Indian institute’s objective evaluation will help confirm the quality of Nanocovax and serve as a foundation for Nanogen to produce the homegrown COVID-19 vaccine for domestic use as well as for export.
THSTI is an institute of the Department of Biotechnology at the Ministry of Science and Technology of India. It has taken part in various vaccine development, assessment and trials in the country.
Nanogen is working with relevant Vietnamese agencies to step up trials of the vaccine candidate so that it will soon receive approval for emergency use in Vietnam./.
Nanogen Pharmaceutical Biotechnology JSC was asked to provide more information regarding safety, immunogenicity, and protection effects before a registration certificate of circulation for its Nano Covax can be granted, Deputy Minister of Health Tran Van Thuan has said.
Deputy Prime Minister Vu Duc Dam has asked for completion of the dossier of the homegrown Nano Covax vaccine to submit for urgent licencing, and assistance for relevant firms in testing the anti-virus drug Molnupiravir in a notice released by the Government Office.
The National Ethics Committee in Biomedical Research under the Ministry of Health on September 19 issued a press statement on its conclusions of a meeting one day earlier during which it looked into the mid-term phase 3 trial’s results of homegrown COVID-19 vaccine Nano Covax.
Vietnam now boasts a nationwide healthcare network with 1,665 hospitals, 384 of which are non-public, supported by local commune- and ward-level stations. At the end of 2024, hospital bed capacity reached 34 per 10,000 people, slightly above the global average.
The 56-year-old patient from Quang Tri province was discharged in stable condition as he no longer experienced shortness of breath and was able to walk, move around, and eat normally.
Associate Professor Dr. Nguyen Vu Trung, Director of the Pasteur Institute, said that under the MoU, the two sides committed to promoting diverse and practical collaborative activities, including joint conferences and workshops, exchanges of scholars, researchers and students, sharing academic materials, and the development of specific programmes and projects in scientific research, training, and epidemic prevention.
TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, and healthcare providers to develop a sustainable digital health ecosystem.
The partnership is under the framework of a Memorandum of Understanding on the development and implementation of the National Action Plan on Breast Cancer and Cervical Cancer Prevention and Control, signed in Hanoi on July 22.
An estimated 7 million Vietnamese are currently living with diabetes, but about 50% remain undiagnosed, a dangerous gap that is fuelling serious, preventable complications and increasing the burden on the healthcare system.
In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in infections driven by the onset of the rainy season.
During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.
The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.
After such a long time, the law has revealed many limitations, prompting the Ministry of Health (MoH) to gather opinions to amend the law to give more chances to thousands of patients every year.
Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.
The centre not only serves residents living on the island, but also receives tens of thousands of visitors every year, according to Assoc Prof Dr Tang Chi Thuong, Director of the HCM CIty Department of Health.
Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.
Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.
During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
Vaccine NanoCovax (Source: Nanogen) 
